Supplement archive

2024

2024, Volume 31, Supplement 3:

Digoxin: its history, modern-day clinical use and toxicity management

2024, Volume 31, Supplement 2:

Embedding innovation in clinical practice to improve patient care across cardiovascular disease

2024, Volume 31, Supplement 1:

Lipoprotein(a) - advances in understanding

2023

2023, Volume 30, Supplement 3:

Inspiring change within the NHS to improve collaborative working and patient care across CVD

2023, Volume 30, Supplement 2:

Managing triglyceride levels to reduce residual cardiovascular risk

2023, Volume 30, Supplement 1:

Overcoming barriers to treating severe aortic stenosis

2022

2022, Volume 29, Supplement 2:

Whats new in heart failure guidance – a users guide

2021

2021, Volume 28, Supplement 1:

Iron deficiency in heart failure

2020

2020, Volume 27, Supplement 2:

Adapting cardiovascular disease care to the new norm of the COVID-19 era – same standard, different delivery

2020, Volume 27, Supplement 1:

Peripheral artery disease in the UK – unmet needs

2019

2019, Volume 26, Supplement 2:

Edoxaban – insights from pivotal studies and sub-analyses

2019, Volume 26, Supplement 1:

Advances in the treatment of chronic heart failure with reduced ejection fraction in real-world settings

2018

2018, Volume 25, Supplement 3:

Advances in cardiac pacing – A 60th anniversary update

2018, Volume 25, Supplement 2:

Management of cardiovascular disease in the patient with diabetes

2018, Volume 25, Supplement 1:

Anticoagulation in atrial fibrillation: focus on PIONEER AF-PCI and its implications

2017

2017, Volume 24, Supplement 1:

Optimising the management of post-ACS patients

2016

2016, Volume 23, Supplement 2:

The future of cardioversion management – new strategies for the use of oral anticoagulation in direct current cardioversion

2016, Volume 23, Supplement 1:

Perspectives in chronic heart failure – new treatment advances

2015

2015, Volume 22, Supplement 1:

Pulmonary hypertension in UK clinical practice – an update

2014

2014, Volume 21, Supplement 2:

Unlocking the potential of NOACs

2014, Volume 21, Supplement 1:

Rivaroxaban in non-valvular atrial fibrillation: European experience

2013

2013, Volume 20, Supplement 2:

Acute heart failure – a call to action

2013, Volume 20, Supplement 1:

Optimising hypertension treatment: NICE/BHS guideline implementation and audit for best practice

2012

2012, Volume 19, Supplement 2:

Chronic stable angina guidelines – is there an emerging international consensus?

2011

2011, Volume 18, Supplement 1:

Setting the standard for cardiac rehabilitation

2010

2010, Volume 17, Supplement 3:

PCI in the UK – the continuing journey

2010, Volume 17, Supplement 2:

Are all angiotensin receptors blockers the same?

2010, Volume 17, Supplement 1: